The New Era of Hepatitis C Virus Therapy

被引：2

作者：

Al-Judaibi, Bandar ^{[1
,2
]}

机构：

[1] Univ Western Ontario, Dept Med, Multiorgan Transplant Unit, London, ON, Canada

[2] King Saud Univ, Dept Med, Div Gastroenterol, Riyadh, Saudi Arabia

来源：

SAUDI JOURNAL OF GASTROENTEROLOGY | 2015年 / 21卷 / 06期

关键词：

Cirrhosis and null responders; direct antiviral agents; hepatitis C virus; HCV GENOTYPE 1; DACLATASVIR PLUS SOFOSBUVIR; TREATMENT-NAIVE PATIENTS; INTERFERON-ALPHA; 2A; PEGYLATED INTERFERON; COMPENSATED CIRRHOSIS; LIVER-TRANSPLANTATION; COMBINATION THERAPY; NATURAL-HISTORY; DOUBLE-BLIND;

D O I：

10.4103/1319-3767.170947

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The hepatitis C virus (HCV) has a significant medical and economic impact on societies around the world, and it has been estimated that 130-180 million people are infected with HCV. Therapies for HCV are currently undergoing a revolution. In recent years, several new treatments have been approved by the United States Food and Drug Administration, and many other treatments are in phase II or III clinical trials, including direct antiviral agents (DAAs). Due to recent major advances in the field of HCV therapy, a summary of findings on new HCV therapies are provided in this review article, including reports on new DAAs.

引用

页码：345 / 354

页数：10

共 73 条

[11] Clinical Characteristics of Patients with Hepatocellular Carcinoma in a Middle Eastern Population [J].

Alswat, Khalid A. ;

Sanai, Faisal M. ;

Altuwaijri, Mansour ;

Albenmousa, Ali ;

Almadi, Majid ;

Al-Hamoudi, Waleed K. ;

Abdo, Ayman A. .

HEPATITIS MONTHLY, 2013, 13 (05)

[12]

[Anonymous], Recommendations for Testing, Managing, and, Treating Hepatitis C

[13] Is screening baby boomers for HCV enough? A call to screen for hepatitis C virus in persons from countries of high endemicity [J].

Asselah, Tarik ;

Perumalswami, Ponni V. ;

Dieterich, Douglas .

LIVER INTERNATIONAL, 2014, 34 (10) :1447-1451

[14] Daclatasvir plus sofosbuvir for HCV infection: An oral combination therapy with high antiviral efficacy [J].

Asselah, Tarik .

JOURNAL OF HEPATOLOGY, 2014, 61 (02) :435-438

[15]

Azzam AZ, 2011, EXP CLIN TRANSPLANT, V9, P323

[16] Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection [J].

Bacon, Bruce R. ;

Gordon, Stuart C. ;

Lawitz, Eric ;

Marcellin, Patrick ;

Vierling, John M. ;

Zeuzem, Stefan ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Boparai, Navdeep ;

Burroughs, Margaret ;

Brass, Clifford A. ;

Albrecht, Janice K. ;

Esteban, Rafael .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) :1207-1217

[17]

Bourliere M, 2014, HEPATOLOGY S, V60, P13

[18] Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease [J].

Charlton, Michael ;

Everson, Gregory T. ;

Flamm, Steven L. ;

Kumar, Princy ;

Landis, Charles ;

Brown, Robert S., Jr. ;

Fried, Michael W. ;

Terrault, Norah A. ;

O'Leary, Jacqueline G. ;

Vargas, Hugo E. ;

Kuo, Alexander ;

Schiff, Eugene ;

Sulkowski, Mark S. ;

Gilroy, Richard ;

Watt, Kymberly D. ;

Brown, Kimberly ;

Kwo, Paul ;

Pungpapong, Surakit ;

Korenblat, Kevin M. ;

Muir, Andrew J. ;

Teperman, Lewis ;

Fontana, Robert J. ;

Denning, Jill ;

Arterburn, Sarah ;

Dvory-Sobol, Hadas ;

Brandt-Sarif, Theo ;

Pang, Phillip S. ;

McHutchison, John G. ;

Reddy, K. Rajender ;

Afdhal, Nezam .

GASTROENTEROLOGY, 2015, 149 (03) :649-659

[19] DACLATASVIR COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION: COMMAND GT2/3 STUDY [J].

Dore, G. J. ;

Lawitz, E. ;

Hezode, C. ;

Shafran, S. ;

Ramji, A. ;

Tatum, H. ;

Taliani, G. ;

Tran, A. ;

Brunetto, M. ;

Zaltron, S. ;

Strasser, S. ;

Weis, N. ;

Ghesquiere, W. ;

Lee, S. ;

Larrey, D. ;

Pol, S. ;

Harley, H. ;

George, J. ;

Fung, S. ;

de Ledinghen, V. ;

Hagens, P. ;

Cohen, D. ;

Cooney, E. ;

Noviello, S. ;

Hughes, E. .

JOURNAL OF HEPATOLOGY, 2013, 58 :S570-S571

[20] Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4 [J].

Doss, Wahid ;

Shiha, Gamal ;

Hassany, Mohamed ;

Soliman, Reham ;

Fouad, Rabab ;

Khairy, Marwa ;

Samir, Waleed ;

Hammad, Radi ;

Kersey, Kathryn ;

Jiang, Deyuan ;

Doehle, Brian ;

Knox, Steven J. ;

Massetto, Benedetta ;

McHutchison, John G. ;

Esmat, Gamal .

JOURNAL OF HEPATOLOGY, 2015, 63 (03) :581-585

← 1 2 3 4 5 6 7 8 →